Results 91 to 100 of about 19,922 (207)

How Does Place of Residence Influence the Experience and Management of Chronic Non‐Malignant Pain? A Systematic Review

European Journal of Pain, Volume 30, Issue 10, November 2026.
ABSTRACT Background and Objective Chronic non‐malignant pain (CNMP) affects up to half of the UK population and one third of adults globally. Rural populations experience poorer health outcomes across several chronic conditions; however, the influence of place of residence on CNMP management, outcomes and experiences remains unclear.
Christiana Stylianou, Rosalind Adam, Fortune Kwushue, Barbara I. Nicholl   +3 more
wiley   +1 more source

Review of duloxetine in the management of diabetic peripheral neuropathic pain

, 2008
Timothy Smith1, Robert A Nicholson21Mercy Health Research Ryan Headache Center, St. Louis, MO, USA; 2Department of Family Medicine, Saint Louis University School of Medicine, St.
Timothy Smith, Robert A Nicholson
core  

A Model for Estimating the Risk of Gastrointestinal Bleeding for Patients on Oral Anticoagulants and Interacting Medications

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 11, November 2026.
ABSTRACT Introduction Pharmacodynamic drug–drug interactions (DDI) in patients receiving oral anticoagulants (OAC) may increase the risk of gastrointestinal bleeding (GIB). The purpose of this study was to develop and validate a GIB model for patients receiving OACs.
Ainhoa Gomez‐Lumbreras, Abdelrahman G. Tawfik, Thomas Reese, Daniel M. Witt, Guilherme Del Fiol, Daniel C. Malone   +5 more
wiley   +1 more source

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan

, 2015
Eiji Harada,1 Alexander Schacht,2 Tsukasa Koyama,3 Lauren Marangell,4,5 Toshinaga Tsuji,6 Rodrigo Escobar41Medical Science, Eli Lilly Japan K.K, Kobe, Japan; 2Global Statistical Sciences, Eli Lilly and Company, Bad Homburg, Germany; 3Clinical Research ...
Schacht A, Tsuji T, Koyama T, Marangell LB, Harada E, Escobar R   +5 more
core  

Regional Nerve Blocks and OnabotulinumtoxinA in the Management of Trigeminal Trophic Syndrome: A Case Report of a Novel Multimodal Approach

Oral Surgery, Volume 19, Issue 4, Page 370-372, November 2026.
ABSTRACT Objective Trigeminal trophic syndrome (TTS) is a rare condition caused by trigeminal nerve injury, classically characterized by anaesthesia, paresthesia and facial ulceration. We present two cases of TTS successfully managed with regional nerve blocks and onabotulinumtoxinA. Methods Two patients—a 54‐year‐old woman and a 65‐year‐old man—with a
Shamin Masrour, Rhea Sudhakaran
wiley   +1 more source

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis

, 2017
Atsushi Kuga,1 Toshinaga Tsuji,2 Shinji Hayashi,2 Mako Matsubara,3 Shinji Fujikoshi,4 Hirofumi Tokuoka,1 Aki Yoshikawa,5 Rodrigo Escobar,6 Kazuhide Tanaka,7 Takaharu Azekawa8 1Bio Medicine, Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe ...
Fujikoshi S, Tsuji T, Escobar R, Hayashi S, Kuga A, Azekawa T, Matsubara M, Yoshikawa A, Tanaka K, Tokuoka H   +9 more
core  

Understanding Chronic Hip Pain Through the ICF Framework: Implications for Assessment, Diagnosis, and Management

Orthopaedic Surgery, Volume 18, Issue 11, Page 2279-2292, November 2026.
Chronic hip pain remains predominantly studied from the perspective of body‐level impairments and symptom management. Using the International Classification of Functioning, Disability and Health (ICF) framework, this review synthesized evidence published between 2020 and 2025 and found that most studies focused on structures and functions, while ...
Mingke You, Kai Zhou, Xi Chen, Xue Zhang, Jian Li, Gang Chen   +5 more
wiley   +1 more source

Use of select medications prior to duloxetine initiation among commercially-insured patients

, 2012
Mark Bernauer,1 Ning Wu,2 Shih-Yin Chen,2 Xiaomei Peng,1 Luke Boulanger,2 Yang Zhao11Eli Lilly and Company, Indianapolis, IN, 2United BioSource Corporation, Lexington, MA, USABackground: The purpose of this study was to assess select medication ...
Peng X, Chen SY, Bernauer M, Wu N, Zhao Y, Boulanger L   +5 more
core  

DULOXETINE-RELATED PANIC ATTACKS [PDF]

, 2011
Side-effects arising on the grounds of antidepressant administration pose as a substantial obstacle hindering successful depressive disorder treatment.
Grahovac, Tanja, Ružić, Klementina, Sabljić, Vladimir, Rakun, Radmir   +3 more
core  

Visual and tactil hallucinations after duloxetine use: a case report

, 2017
Duloxetine is a serotonin-noradrenaline reuptake inhibitor. In addition to major depressive disorder treatment, it is also used effectively in the treatment of diabetic neuropathic pain and fibromyalgia syndrome.
Akbey, Zeynep Yildiz, Turan, Hatice, Fatma Eren, Nermin Gündüz, Gunduz, NERMİN, Zeynep Akbey, Eren, Fatma, Hatice Turan   +7 more
core   +1 more source